Health Trials

Congenital Factor VII Deficiency

1

Review clinical trials related to Congenital Factor VII Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency

Open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of a single dose of sutacimig monotherapy in participants with congenital FVII deficiency (FVIID).

Participants needed: 18
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: Hemab ApSUpdated: May 29, 2026Locations: 1
Eligibility criteria

Age 18 to 60 years, inclusive, at the time of signing informed consent. [+3]

Presence of known inhibitors to FVII or FVIIa [+6]

Read more